Publications

Export 6 results:
Author Title [ Type(Asc)] Year
Filters: Author is Chavez, Sofia  [Clear All Filters]
Journal Article
Plitman E, Chavez S, Nakajima S, Iwata Y, Chung JKu, Caravaggio F, Kim J, Alshehri Y, M Chakravarty M, De Luca V et al..  2018.  Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.. Psychiatry Res Neuroimaging. 273:16-24.
Kim J, Plitman E, Iwata Y, Nakajima S, Mar W, Patel R, Chavez S, Chung JKu, Caravaggio F, M Chakravarty M et al..  2019.  Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders.. Prog Neuropsychopharmacol Biol Psychiatry. :109839.
Amaral RSC, Park MTae M, Devenyi GA, Lynn V, Pipitone J, Winterburn J, Chavez S, Schira M, Lobaugh NJ, Voineskos AN et al..  2016.  Manual segmentation of the fornix, fimbria, and alveus on high-resolution 3T MRI: Application via fully-automated mapping of the human memory circuit white and grey matter in healthy and pathological aging.. Neuroimage.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M et al..  2019.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
Plitman E, Patel R, Chung JKu, Pipitone J, Chavez S, Reyes-Madrigal F, Gómez-Cruz G, León-Ortiz P, M Chakravarty M, de la Fuente-Sandoval C et al..  2016.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.. Neuropsychopharmacology. 41(10):2606-13.
Park MTae M, Pipitone J, Baer LH, Winterburn JL, Shah Y, Chavez S, Schira MM, Lobaugh NJ, Lerch JP, Voineskos AN et al..  2014.  Derivation of high-resolution MRI atlases of the human cerebellum at 3T and segmentation using multiple automatically generated templates.. Neuroimage. 95:217-31.